These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 6035343)

  • 1. Irreversible enzyme inhibitors. XCII. Inhibition of xanthine oxidase by some purines and pyrimidines.
    Baker BR; Hendrickson JL
    J Pharm Sci; 1967 Aug; 56(8):955-9. PubMed ID: 6035343
    [No Abstract]   [Full Text] [Related]  

  • 2. THE EFFECTIVENESS OF THE XANTHINE OXIDASE INHIBITOR ALLOPURINOL IN THE TREATMENT OF GOUT.
    KLINENBERG JR; GOLDFINGER SE; SEEGMILLER JE
    Ann Intern Med; 1965 Apr; 62():639-47. PubMed ID: 14274828
    [No Abstract]   [Full Text] [Related]  

  • 3. [TREATMENT OF GOUTY DYSPURINIA BY PARAMETABOLITES AND, ESPECIALLY, BY A XANTHINE OXIDASE INHIBITOR].
    DELBARRE F; AUSCHER C; LABROUSSE C; GERYA DE
    Presse Med (1893); 1965 May; 73():1275-9. PubMed ID: 14273211
    [No Abstract]   [Full Text] [Related]  

  • 4. Irreversible enzyme inhibitors. CXXVI. Hydrocarbon interaction with xanthine oxidase by phenyl substituents on purines and pyrazolo[3,4-d]pyrimidines.
    Baker BR; Wood WF; Kozma JA
    J Med Chem; 1968 Jul; 11(4):661-6. PubMed ID: 5671224
    [No Abstract]   [Full Text] [Related]  

  • 5. Irreversible enzyme inhibitors. CXXV. Active-site-directed irreversible inhibitors of xanthine oxidase derived from arylpurines and pyrazolo[3,4-d]pyrimidines bearing a terminal sulfonyl fluoride.
    Baker BR; Kozma JA
    J Med Chem; 1968 Jul; 11(4):656-61. PubMed ID: 5671223
    [No Abstract]   [Full Text] [Related]  

  • 6. THE RENAL EXCRETION OF OXYPURINES.
    GOLDFINGER S; KLINENBERG JR; SEEGMILLER JE
    J Clin Invest; 1965 Apr; 44(4):623-8. PubMed ID: 14278178
    [No Abstract]   [Full Text] [Related]  

  • 7. Allopurinol, purines, and pyrimidines.
    Lancet; 1971 Jan; 1(7689):73. PubMed ID: 4099227
    [No Abstract]   [Full Text] [Related]  

  • 8. A comparative study of the xanthine oxidase inhibitors allopurinol and oxipurinol in man.
    Chalmers RA; Krömer H; Scott JT; Watts RW
    Clin Sci; 1968 Oct; 35(2):353-62. PubMed ID: 5721238
    [No Abstract]   [Full Text] [Related]  

  • 9. Synthesis and enzymic activity of some novel xanthine oxidase inhibitors. 3-Substituted 5,7-dihydroxypyrazolo(1,5-alpha)pyrimidines.
    Springer RH; Dimmitt MK; Novinson T; O'Brien DE; Robins RK; Simon LN; Miller JP
    J Med Chem; 1976 Feb; 19(2):291-6. PubMed ID: 2778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. On the mechanism of inactivation of xanthine oxidase by allopurinol and other pyrazolo[3,4-d]pyrimidines.
    Massey V; Komai H; Palmer G; Elion GB
    J Biol Chem; 1970 Jun; 245(11):2837-44. PubMed ID: 5467924
    [No Abstract]   [Full Text] [Related]  

  • 11. Synthesis and biological evaluation of new imidazole, pyrimidine, and purine derivatives and analogs as inhibitors of xanthine oxidase.
    Biagi G; Costantini A; Costantino L; Giorgi I; Livi O; Pecorari P; Rinaldi M; Scartoni V
    J Med Chem; 1996 Jun; 39(13):2529-35. PubMed ID: 8691450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of allopurinol (4-hydroxyprazolo(3,4-d)pyrimidine) on xanthine accumulation by milk xanthine oxidase in vitro.
    Jezewska MM
    Eur J Biochem; 1974 Jul; 46(2):361-5. PubMed ID: 4408204
    [No Abstract]   [Full Text] [Related]  

  • 13. The conversion of 4-hydroxypyrazolo[3,4-d]pyrimidine (allopurinol) into 4,6-dihroxypyrazolo[3,4-d]pyrimidine (Oxipurinol) in vivo in the absence of xanthine-oxen oxidoreductase.
    Chalmers RA; Parker R; Simmonds HA; Snedden W; Watts RW
    Biochem J; 1969 May; 112(4):527-32. PubMed ID: 5801674
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between plasma oxipurinol concentrations and xanthine oxidase activity in volunteers dosed with allopurinol.
    Day RO; Miners J; Birkett DJ; Graham GG; Whitehead A
    Br J Clin Pharmacol; 1988 Oct; 26(4):429-34. PubMed ID: 3190993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pyrazolo- and triazolopyrimidines as inhibitors of tryptophan pyrrolase.
    Becking GC; Johnson WJ
    Life Sci; 1969 Aug; 8(16):843-51. PubMed ID: 5803378
    [No Abstract]   [Full Text] [Related]  

  • 16. Oxypurinol as an inhibitor of xanthine oxidase-catalyzed production of superoxide radical.
    Spector T
    Biochem Pharmacol; 1988 Jan; 37(2):349-52. PubMed ID: 2829916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The screening and characterization of 6-aminopurine-based xanthine oxidase inhibitors.
    Hsieh JF; Wu SH; Yang YL; Choong KF; Chen ST
    Bioorg Med Chem; 2007 May; 15(10):3450-6. PubMed ID: 17379526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Purine metabolism and inhibition of xanthine oxidase in severely hypoxic neonates going onto extracorporeal membrane oxygenation.
    Marro PJ; Baumgart S; Delivoria-Papadopoulos M; Zirin S; Corcoran L; McGaurn SP; Davis LE; Clancy RR
    Pediatr Res; 1997 Apr; 41(4 Pt 1):513-20. PubMed ID: 9098853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The influence of allopurinol on purine- and pyrimidinesynthesis (author's transl)].
    Gröbner W; Zöllner N
    Klin Wochenschr; 1978 Mar; 53(16):255-60. PubMed ID: 682520
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of allopurinol on oxypurine excretion in xanthinuria.
    Salti IS; Kattuah N; Alam S; Wehby V; Frayha R
    J Rheumatol; 1976 Jun; 3(2):201-4. PubMed ID: 950637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.